HydrogelsLower Urinary Tract SymptomsProstatic Neoplasms
Dr. Josephine Kang, MD, PhD
NPI1760654636
- Medicare services, 2019
- 333
- Part D claims, 2020
- 19
- Publications
- 37
- Clinical trials
- 4
- MIPS score, 2024
- 100
- Practice address
- NY
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Find Dr. Kang's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Josephine Kang is a radiation oncologist in New York
Dr. Kang practices in New York.
Dr. Kang's NPI, 1760654636, was assigned on March 31, 2008. Dr. Kang graduated from New York University School of Medicine in 2007. Dr. Kang holds New York license 265244.
NPI and contact details
- NPI
- 1760654636NPI Registry (opens in a new tab)
- NPI enumeration date
- March 31, 2008
- NPI status
- Active
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
- Estimated age
- 45
- Medical school graduation
- 2007
Sources: NPPES NPI Registry (CMS); and Dmand AI Professional Profile Data
Dmand AI tracks the EHR system at Dr. Josephine Kang's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kang practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Dr. Kang's practice | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Dr. Kang practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Josephine Kang is one of 385 radiation oncologists in New York
Radiation oncology is Dr. Kang's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Kang is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Kang's licenses on file in 2 states: New York and Massachusetts.
Specialties and state licenses
- Radiation oncology, New YorkPrimary
- Massachusetts license
Radiation oncologists near Dr. Kang
Counts of radiation oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Josephine Kang billed Medicare for 333 services in 2019
CMS data shows 333 Medicare services from Dr. Kang across 7 procedure codes in 2019. Medicare paid $19,725 for them. Every service was in a facility, such as a hospital, rather than an office.
Medicare services, 2019333
Paid by Medicare$19,725
Procedure codes7
Dr. Kang's Medicare services by type, 2018 to 2019
- 2018
- 2019
- Imaging
- 2018: 4912019: 31137%
- Office and hospital visits
- 2018: 322019: 2231%
Dr. Kang compared with the New York median for radiation oncologists, 2019
- Dr. Kang
- New York median
- Medicare services
- 333vs 1,05468% below
- Part D claims
- 19vs 3647% below
Medians across 368 radiation oncologists in New York with Dmand AI profiles that report each measure.
Dr. Kang's most billed Medicare procedure codes, 2019
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Kang?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Kang and other radiation oncologists in New York.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Josephine Kang's patients have a median age of 33
Across all payers, Dmand AI patient panel data puts Dr. Kang's median patient age at 33, with 100% women.
Dr. Kang's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 33
Patient panel by sex, all payers
- Women100%
- Men0%
Source: Dmand AI Patient Panel Data
Dr. Josephine Kang wrote 19 Medicare Part D claims in 2020
In 2020, Dr. Kang wrote 19 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $157 in total drug cost. In 2019, CMS named 18 claims across 1 drug.
Part D claims, 202019
Drugs named by CMS1
Total drug cost$157
Dr. Kang's most prescribed drugs by claims, 2020
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2019 to 2020
- 2019
- 2020
- Claims for drugs CMS names
- 2019: 182020: 196%
Drugs named by CMS: 1 in 2020, 1 in 2019.
Source: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026
Dr. Josephine Kang scored 100 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Kang for performance year 2024, reported through an alternative payment model (APM).
Dr. Kang's MIPS scores, performance year 2024
- 100of 100Final score
- 85.3of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Source: Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Find radiation oncologists like Dr. Kang by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Josephine Kang has 37 publications on record
Dmand AI links 37 papers to Dr. Kang, published from 2011 to 2022. 2014 was the busiest year, with 6. The most frequent topics are Prostatic Neoplasms, Radiosurgery and Black or African American. Dr. Kang has published most often in Front Oncol. Dr. Kang's most frequent co-authors are David Li, MD, PhD, Himanshu Nagar, MD and Silvia C. Formenti, MD.
Papers37
Years published2011 to 2022
Dr. Kang's papers by year, 2011 to 2022
Topics Dr. Kang writes about most
- Prostatic Neoplasms
- Radiosurgery
- Black or African American
- Area Under Curve
- Gene Expression Regulation, Neoplastic
- Hydrogels
- Neoplasm Grading
- Palliative Care
Dr. Kang's most frequent co-authors
- David Li, MD, PhD4 shared papers
- Himanshu Nagar, MD4 shared papers
- Silvia C. Formenti, MD3 shared papers
Recent publications by Dr. Kang
J Appl Clin Med Phys
HydrogelsMagnetic Resonance ImagingOrgans at Risk
JAMA Netw Open
Androgen AntagonistsBlack or African AmericanHealthcare Disparities
Eur Urol Oncol
ImmunotherapyUrogenital Neoplasms
See who Dr. Kang researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Kang works with, so you can find a warm path to the right radiation oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Josephine Kang has worked on 4 clinical trials
Dmand AI links Dr. Kang to 4 clinical trials. 1 is still active or recruiting. Conditions studied include Prostatic Neoplasms and Prostatic Diseases. Weill Medical College of Cornell University sponsors the most, 4.
Conditions in Dr. Kang's trials
- Prostatic Neoplasms
- Prostatic Diseases
Investigators on the most trials with Dr. Kang
Recent clinical trials with Dr. Kang
Prostatic NeoplasmsProstatic DiseasesPSMA PET/MR - Gallium-68 labeled PSMA-HBED-CCStereotactic Body Radiation Therapy (SBRT)
Prostatic NeoplasmsProstatic DiseasesMR-Guided Prostate SBRT
Prostatic NeoplasmsProstatic DiseasesSIBRT
Prostatic NeoplasmsProstatic DiseasesRadiation therapyEndorectal BalloonRectal Spacer
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Josephine Kang received $1,543 in industry payments from 2016 to 2019
CMS Open Payments shows 19 general payments to Dr. Kang from 7 drug and device companies from 2016 to 2019. Food and beverage make up the largest share, 67% of the total. Varian Medical Systems, Inc. paid the most, $1,092.
General payments to Dr. Kang by program year, 2016 to 2019
General payments to Dr. Kang by kind, 2016 to 2019
$1.5Kin total
- Food and beverage$1,02967%
- Travel and lodging$51433%
Companies that paid Dr. Kang the most, 2016 to 2019
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Josephine Kang graduated from New York University School of Medicine
Dr. Kang graduated from New York University School of Medicine in 2007.
- Medical school
- Board certified in radiation oncology
Source: Dmand AI Professional Profile Data
Dr. Josephine Kang accepts plans from 15 insurance carriers
Dr. Kang is in network with 15 carriers, including Elevance, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.
- Elevance
- Blue Cross Blue Shield of Michigan
- United Healthcare
- HCSC
- Blue Cross Blue Shield of Massachusetts
- Cigna
- MVP Health Care
- Regence Health Plans
- +7 more carriersWith a free account
Plan types Dr. Kang accepts, by number of carriers
- PPO9
- Medicare8
- HMO7
- EPO3
- POS3
- Medicaid1
Source: Dmand AI Insurance Network Data
Sources for Dr. Josephine Kang's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Josephine Kang
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Josephine Kang's NPI number?
Dr. Josephine Kang's NPI number is 1760654636. It was assigned on March 31, 2008, and it is active in the NPI Registry.
What kind of doctor is Dr. Josephine Kang?
Dr. Josephine Kang is a radiation oncologist in New York. The primary specialty in the NPI Registry is Radiation Oncology Physician (taxonomy code 2085R0001X).
What is Dr. Josephine Kang's medical license number?
Dr. Kang holds New York license 265244, one of the licenses on file in 2 states.
Which states has Dr. Josephine Kang been licensed in?
Dmand AI has state licenses on file for Dr. Kang in New York (2012 to 2026) and Massachusetts (2008 to 2013).
Does Dr. Josephine Kang accept Medicare?
Yes. CMS data shows Dr. Kang billed Medicare for 333 services in 2019.
What is Dr. Josephine Kang's MIPS score?
Dr. Kang's MIPS final score for performance year 2024 is 100 out of 100, reported through an alternative payment model (APM).
Is Dr. Josephine Kang board certified?
Yes. Dr. Kang is board certified in radiation oncology by the American Board of Radiology.
What services does Dr. Josephine Kang bill to Medicare?
In 2019, Dr. Kang's most billed Medicare services were radiation oncology (77300), radiation oncology (77334) and office visit, new patient (99205).
Where did Dr. Josephine Kang go to medical school?
Dr. Kang graduated from New York University School of Medicine in 2007.
What drugs does Dr. Josephine Kang prescribe most?
In 2020 Medicare Part D data, Dr. Kang's most prescribed drugs by claims were Tamsulosin HCl.
Show 5 more questionsShow fewer questions
Has Dr. Josephine Kang received payments from drug or device companies?
CMS Open Payments shows $1,543 in general payments to Dr. Kang from 7 companies from 2016 to 2019. The largest total came from Varian Medical Systems, Inc.
How long has Dr. Josephine Kang been practicing?
Dr. Kang graduated from medical school in 2007, 19 years ago.
Does Dr. Josephine Kang do research?
Dmand AI links 37 publications to Dr. Kang, published from 2011 to 2022. Dr. Kang has worked on 4 clinical trials.
Who does Dr. Josephine Kang publish with?
Dr. Kang's most frequent co-authors are David Li, MD, PhD (4 shared papers), Himanshu Nagar, MD (4 shared papers) and Silvia C. Formenti, MD (3 shared papers).
What insurance does Dr. Josephine Kang accept?
Dr. Kang is in network with 15 carriers, including Elevance, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.
Selling to radiation oncology practices?
See radiation oncologists in New York by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card